Identifies, establishes, and maintains collaborative relationships with key investigators and institutions in disease state areas of strategic focus.
Provides education to the medical community on the company’s investigational products and disease areas of focus.
Increases company visibility and enhances professional interaction with current and future oncology leaders.
Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, the company has a global team of over 100 employees headquartered in Boston, with a focus on advancing its lead asset, ficerafusp alfa.
Own the end-to-end franchise strategy for NavDx across HPV-driven cancers, accountable for volume, revenue, and market share.
Lead market shaping and medical education to redefine standards of care in surveillance and MRD monitoring.
Drive upstream and downstream marketing, sales, and cross-functional alignment to accelerate adoption and guideline inclusion.
CareDx is a leading precision medicine solutions company focused on transplant patients, offering products, testing services, and digital healthcare solutions. The company fosters a collaborative culture with a mission to improve patient lives and provides competitive total rewards.
Establish and maintain scientific relationships with oncology healthcare providers and key opinion leaders.
Deliver accurate, balanced, and clinically relevant education on Natera's oncology molecular diagnostics.
Identify and communicate field insights including oncology treatment trends and unmet clinical needs.
Natera is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. The team consists of highly dedicated professionals from world-class institutions who care deeply for their work and each other.